LEXINGTON, Mass.--(BUSINESS WIRE)--Predictive Biosciences, a leading provider of cancer diagnostic products and services, today announced the appointment of industry veteran Kim Blickenstaff as the seventh member of the Company’s board of directors. Mr. Blickenstaff, currently president and chief executive officer of Tandem Diabetes Care, Inc., brings extensive medical device and diagnostics experience to Predictive.
